Broksinak of a drop of eyes. 0.09% fl. 1.7 ml No. 1

Drops eye Broksinak is shown for treatment of postoperative inflammation and reduction of pain at patients after extraction of a cataract.

Structure

Active ingredient: bromfenac;

1 ml of solution of eye drops bromfenak sodium of sexivihydrat that is equivalent to a bromfenak of free acid - 0.9 mg;

Excipients: a benzalkoniya chloride, boric acid, sodium edetat, polysorbate 80, K-30 povidone, bornokisly sodium, sodium sulfite waterless (E 221), sodium hydroxide, water for injections.

Contraindication

Hypersensitivity to any of medicine components and also to other NPVP.

use of medicine Is contraindicated to patients at whom attacks of bronchial asthma, a small tortoiseshell and symptoms of sharp rhinitis amplify at intake of acetylsalicylic acid and other non-steroidal anti-inflammatory drugs.

application Is contraindicated to patients aged up to 18 years (safety and efficiency of use of medicine for children were not investigated).

Route of administration

recommend instillations in a conjunctival sac on 1 drop once a day. Treatment is begun in 1 day prior to surgical intervention and continued during the first 14 days of the postoperative period (including day of operation). Before introduction of eye drops it is necessary to remove contact lenses. It is again possible to establish them in 15 minutes after burying.

At use of several eye medicines of local action the interval between their introduction has to make not less than 5 minutes.

in case of the admission of administration of medicament should apply medicaments rather in a dose which is provided by the instruction. If after the admission there passed nearly 24 h, medicament should be used in following is intended time, doubling a dose for compensation which is missed.

For elderly patients from that at younger patients.

Pregnant

Use of medicine is possible

Feature of application

Should avoid prescribing of medicine in the III trimester of pregnancy.

Children

It is contraindicated.

Drivers

Drug slightly affects ability to steer motor transport or mechanisms. Perhaps short-term turbidity of sight after administration of medicine therefore it is recommended to wait before complete recovery of sight before starting control of transport mechanisms.

in case of overdose the irritation of eyes and hyperaemia of a conjunctiva is possible

.

At accidental use of medicine inside needs to drink immediately a large amount of liquid for decrease in concentration of medicine in a stomach and to see a doctor.

Side effects

• from an organ of sight: feeling of discomfort and unusual feelings in eyes, irritation of eyes, pain, an itch and burning in eyes, reddening of eyes, conjunctiva hyperaemia, inflammation of an iris of the eye of eyes. There is single post-marketing a message about an erosion of a cornea, perforation of a cornea, thinning of a cornea, destruction of an epithelium of a cornea.
• from nervous system: headache.
• from a respiratory system: nasal bleeding, cough, discharges from a nose, bronchial asthma.
• General violations: face edema.

Drug can be used by

along with other ophthalmologic medicines of a α-adrenomimetikama, β-adrenoblockers, inhibitors of a karboangidraza, midriatika. At the same time it is necessary to use medicaments with a break not less than five minutes.

Storage conditions

to Store

at a temperature not above 25 °C in original packing.

to Store

out of children's reach.

Expiration date - 2 years.

Expiration date after opening of a bottle of 16 days.

not to apply

after the expiry date specified on packing.